HOME Top Market Reports High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018

By: marketsandmarkets.com
Publishing Date: February 2014
Report Code: BT 2220

 

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The global HTS market was valued at $13.7 billion in 2013 and is expected to grow at a CAGR of 7.4% over the next five years. A number of factors such as technological innovations, increasing adoption of open innovation models by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in HTS technology by organizations are driving the growth of this market. The HTS market is segmented on the basis of technology, products, applications, end users, and geography. The global HCS market report studies the market estimations and trends for the above mentioned segments in four geographies, namely, North America, Europe, Asia, and RoW (Rest of the World). The growth in outsourcing of drug discovery services, especially in China and India, and the presence of a large untapped market in emerging countries are the factors that are expected to present growth opportunities to players in the HTS market. However, factors such as the capital intensive nature of HTS and difficulties in assay development for novel target classes are hampering the growth of this market.

The market is expected to witness a high growth in the label-free technology segment, as this technology offers direct detection. Moreover, this technology helps in reducing drug failure due to toxicity and can be applied to majority of drug classes. The consumables/reagents market within the products segment is estimated to grow at a high CAGR from 2013 to 2018. The accessibility of a wide range of reagents, and product developments and innovations are driving the growth of this market.

According to industry experts, owing to the shortage of strong candidates in the product pipeline of biopharmaceutical companies and high R&D costs, companies are increasingly adopting high-throughput screening (HTS) techniques. This increase in capital investments in HTS indicates the rising adoption of HTS technology across several applications. Significant technological breakthroughs such as label-free methods, advancements in genomics and proteomics research, and growth in outsourcing of drug discovery services are providing new opportunities for growth in the HTS market.

North America accounted for the largest share of the global HTS market, followed by Europe. Asia is expected to grow at the highest CAGR during the study period. The growth in government funding and increase in the number of drug discovery services by contract research organizations are the major factors having a positive impact on this market. Markets like China and India are potential markets for investors in the near future.

The key players in the global HTS market are Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.), and Tecan Group (Switzerland).

Scope of the Report

High Throughput Screening (HTS) is a drug-discovery process that leverages automation to quickly assay the biochemical activity of numerous drug-like compounds. The invention of microtiter plate and development of laboratory-specific plate readers led to the adoption of the HTS platform in laboratories. This study covers the technologies, products, applications, and end-users revenue markets in the global HTS market.

The sales volume of HTS products is not in the scope of this report.

Global HTS Market

The global HTS market has been segmented according to products, technologies, applications, end-users, and geography.

High Throughput Screening (HTS) market, by Technology

  • Cell-Based Assay
  • Ultra high throughput screening (uHTS)Lab-on-a-chip
  • Label Free Technology
  • Bioinformatics

High Throughput Screening (HTS) market, by Product

  • Instruments
  • Consumables/Reagents
  • Software and Services

High Throughput Screening (HTS) market, by Application

  • Target Identification
  • Primary Screening
  • Toxicology
  • Stem Cell Biology
  • Others

High Throughput Screening (HTS) market, by End User

  • Pharmaceutical
  • Biotechnology
  • Academic & Government Organizations
  • Contract Research Organizations
  • Others

High Throughput Screening (HTS) market, by Geography

  • North America
  • Europe
  • Asia
  • RoW

Customization Options:

With Market data, you can also get options to include market assessments that meet your Company’s specific needs. Following customization options are being offered with procurement of this market research report:

  1. Country Level Market Data
    • North America (U.S. and Canada)
    • Europe (U.K., Germany, France, Italy, Spain and Rest of Europe)
    • Asia (Japan, China, India, and Rest of Asia)
    • Rest of the World (Latin America, Middle East and Africa)
  2. High Throughput Screening (HTS) market – Regional market share analysis by key players
    • North America
    • Europe
    • Asia
  3. Partnership Analysis (Free customization)
    • SWOT analysis of top 10 companies and strategic recommendation with reasoning for considering these as a future partner
  4. Additional Company Profiles (Free customization)
    • Additional 5 companies can be profiled apart from those profiled in the report

Options (1) and (2) shall carry additional cost.

Table Of Contents
 
1 Introduction (Page No. - 19)
   1.1 Objectives of The Study
   1.2 Report Description
   1.3 Markets Covered
   1.4 Stakeholders
   1.5 Market Scope
   1.6 Research Methodology
        1.6.1 Secondary Sources
        1.6.2 Primary Sources
        1.6.3 Market Size Estimation
        1.6.4 Market Share
        1.6.5 Key Data Points From Secondary Sources
        1.6.6 Key Data Points From Primary Sources
        1.6.7 Assumptions

2 Executive Summary (Page No. - 36)

3 Premium Insights (Page No. - 40)
   3.1 HTS Market - A Sub-Segment of Drug Discovery Market
   3.2 Global HTS Market
   3.3 Market Dynamics
   3.4 Geographic Analysis & HTS Technologies Market
   3.5 Technology Market
   3.6 End-User Analysis
   3.7 Competitive Analysis

4 Market Overview (Page No. - 47)
   4.1 Introduction
   4.2 Technology Evolution
   4.3 Market Segmentation
   4.4 Market Dynamics
        4.4.1 Drivers
                 4.4.1.1 Adoption of Open Innovation Models By Pharmaceutical Companies to Increase The Use of HTS
                 4.4.1.2 Increasing Drug Discovery Initiatives By Academic and Government Institutions to Boost The Demand for HTS Products
                 4.4.1.3 Increasing Capital Investments in HTS Technology By Organizations Lead to The Growth of HTS
                 4.4.1.4 Technological Advancements in Research Leading to Large Potential Candidates for Screening Will Help HTS
                 4.4.1.5 Increase in The Number of Outsourced Drug Discovery Services Will Propel The HTS Market
        4.4.2 Restraints
                 4.4.2.1 The Capital-Intensive Nature of HTS Will Hamper The Growth of This Market
                 4.4.2.2 Assay Development for HTS Becoming Difficult for New Target Classes
        4.4.3 Opportunities
                 4.4.3.1 Growing Asian Market to Boost The HTS Market
                 4.4.3.2 High Throughput Cellular Microarrays Increasingly Being Used in toxicology and Stem Cell Research, Thus Prompting Its Growth
                 4.4.3.3 Growth of Contract Research Organizations (Cros) in Emerging Countries to Bolster The HTS Market
                 4.4.3.4 Label-Free Technology Emerging As A Valuable Tool for Drug Discovery
   4.5 Trends
         4.5.1 Label-Free Method Gaining Importance in HTS Labs
         4.5.2 HTS Techniques Increasingly Being Used in The Field of Toxicology
         4.5.3 Automation & Miniaturization of HTS Techniques
   4.6 Strategic Benchmarking
         4.6.1 New Product Launches
                  4.6.1.1 Agilent Technologies Introduced The Rapidfire 365 High Throughput Mass Spectrometry System
                  4.6.1.2 Perkinelmer Introduced The Janus Biotx Pro Automated Workstation
                  4.6.1.3 Beckman Coulter Introduced The Navios Flow Cytometry System
                  4.6.1.4 Sigma-Aldrich Introduced The Compozr Transporter Knockout Human Cell Lines in Plate format
                  4.6.1.5 Tecan Group Introduced Dako Omnis
       4.6.2 Technology Integration
                4.6.2.1 Collaboration Between Agilent & Baylor College of Medicine's Medical Genetics Laboratories
                4.6.2.2 Collaboration Between Perkinelmer & The National Center for Drug Screening (Ncds)
                4.6.2.3 Partnership of Beckman Coulter With Illumina
                4.6.2.4 Agreement of Sigma-Aldrich Corporation With Alphagenix
                4.6.2.5 Agreement of Tecan Group With Tap Biosystems
   4.7 Value Chain Analysis
   4.8 Porter’s Five Forces Analysis
         4.8.1 Threat From New Entrants
         4.8.2 Threat From Substitutes
         4.8.3 Bargaining Power of Buyers
         4.8.4 Bargaining Power of Suppliers
         4.8.5 Competitive Rivalry Among Existing Players
   4.9 Key Player Analysis

5 By Technology (Page No. - 72)
   5.1 Introduction
   5.2 Cell-Based Assays
         5.2.1 Cell-Based Assays Are Used in More Than 50% of HTS Assays
   5.3 Ultra High Throughput Screening (UHTS)
         5.3.1 UHTS Increasers The Number of Potential Drug Candidates Tested Per Day
   5.4 Lab-On-A-Chip (Loac)
         5.4.1 Loac Market to Grow At A High Pace
   5.5 Label-Free Technology
         5.5.1 Label-Free Technology to Grow At The Fastest Pace in HTS Market
   5.6 Bioinformatics
         5.6.1 Bioinformatics Reduces The Cost and Duration of Drug Discovery Process

6 By Product (Page No. - 83)
   6.1 Introduction
   6.2 Instruments
         6.2.1 The Demand for Automated and Easy-to-Use Systems On A Rise
   6.3 Consumables/Reagents
         6.3.1 Assay Kits to Drive The HTS Market
   6.4 Software & Services
         6.4.1 Outsourcing to Drive The HTS Services Market

7 By Application (Page No. - 91)
   7.1 Introduction
   7.2 Target Identification
         7.2.1 Target Identification Segment Occupies The Largest Share of HTS Applications Market
   7.3 Primary Screening
         7.3.1 Primary Screening is The Second Largest HTS Applications Market
   7.4 Toxicology
         7.4.1 Recent Advancements Present Significant Opportunities for Toxicity Testing
   7.5 Stem Cell Biology
         7.5.1 Stem Cells Provide Significant Advantages to HTS Technology
   7.6 Other Applications

8 By End Users (Page No. - 102)
   8.1 Introduction
   8.2 Pharmaceutical & Biotechnology Industry
         8.2.1 Pharmaceutical Companies Are The Biggest End-Users for HTS
   8.3 Academic & Government Institutes
         8.3.1 Open Innovation to Drive The HTS Market in Government Sector
   8.4 Contract Research Organizations (Cro)
         8.4.1 Emerging Countries to Drive The HTS Market for Cro
   8.5 Other Industries (Hospitals/Clinics, Agriculture, Environmental Labs)

9 Geographic Analysis (Page No. - 113)
   9.1 Introduction
   9.2 North America
         9.2.1 Rising Investments By Drug Discovery Companies to Drive The North American HTS Market
         9.2.2 Collaborations Between Companies and Academic Institutes On A Rise
   9.3 Europe
         9.3.1 Public-Private Partnerships to Goad The European HTS Market
   9.4 Asia
         9.4.1 Government Initiatives Provide Scope for Growth of HTS Market in Asia
   9.5 Rest of The World (ROW)
 
10 Competitive Landscape (Page No. - 161)
   10.1 Introduction
           10.1.1 New Product Launch, The Key Growth Strategy Adopted By HTS Players
           10.1.2 New Product Launch
           10.1.3 Agreements, Partnerships, and Collaborations
           10.1.4 Mergers & Acquisitions
           10.1.5 Expansions
           10.1.6 Other Developments

11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. - 170)
   11.1 Agilent Technologies, Inc.
   11.2 Aurora Biomed
   11.3 Axxam Spa
   11.4 Beckman Coulter, Inc. (A Subsidiary of Danaher)
   11.5 Bio-Rad Laboratories
   11.6 Biofocus Dpi Ltd.
   11.7 Intellicyt Corporation
   11.8 Luminex Corporation
   11.9 Perkinelmer, Inc.
   11.10 Sigma Aldrich Corporation
   11.11 Tecan Group Ltd.
   11.12 Thermo Fisher Scientific, Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

Appendix (Page No. - 232)


List of Tables (75 Tables)

Table 1 Global High Throughput Screening Market, By Technology, 2011–2018 ($Million)
Table 2 HTS Market, By Technology, 2011–2018 ($Million)
Table 3 Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 4 Ultra High Throughput Screening Market, By Geography, 2011–2018 ($Million)
Table 5 Lab-on-A-Chip Market, By Geography, 2011–2018 ($Million)
Table 6 Label-Free Technology Market, By Geography, 2011–2018 ($Million)
Table 7 Bioinformatics Market, By Geography, 2011–2018 ($Million)
Table 8 HTS Market, By Product,2011–2018 ($Million)
Table 9 HTS Instruments Market, By Geography, 2011–2018 ($Million)
Table 10 HTS Consumables/Reagents Market, By Geography, 2011–2018 ($Million)
Table 11 HTS Software & Services Market, By Geography, 2011–2018 ($Million)
Table 12 HTS Market, By Application, 2011–2018 ($Million)
Table 13 HTS Target Identification Market, By Geography, 2011–2018 ($Million)
Table 14 HTS Primary Screening Market, By Geography, 2011–2018 ($Million)
Table 15 HTS Toxicology Market, By Geography, 2011–2018 ($Million)
Table 16 HTS Stem Cell Biology Market, By Geography, 2011–2018 ($Million)
Table 17 HTS Other Applications Market, By Geography, 2011–2018 ($Million)
Table 18 Global Market Revenue, By End User, 2011–2018 ($Million)
Table 19 Pharmaceutical: HTS Market, By Geography, 2011–2018 ($Million)
Table 20 Biotechnology: HTS Market, By Geography, 2011–2018 ($Million)
Table 21 Academic & Government: HTS Market, By Geography, 2011–2018 ($Million)
Table 22 Contract Research Organization: HTS Market, By Geography, 2011–2018 ($Million)
Table 23 Other Industries: HTS Market, By Geography, 2011–2018 ($Million)
Table 24 Global High Throughput Screening Market Revenue, By Geography, 2011–2018 ($Million)
Table 25 North America: Market, By Technology, 2011–2018 ($Million)
Table 26 North America: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 27 North America: Ultra High Throughput Screening Market, By End User, 2011–2018 ($Million)
Table 28 North America: Lab–on-A-Chip Market, By End User, 2011–2018 ($Million)
Table 29 North America: Label-Free Technology Market, By End User, 2011–2018 ($Million)
Table 30 North America: Market, By Product, 2011–2018 ($Million)
Table 31 North America: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 32 North America: Ultra High Throughput Screening Market, By Product, 2011–2018 ($Million)
Table 33 North America: Lab-on-A-Chip Market, By Product, 2011–2018 ($Million)
Table 34 North America: Label-Free Technology Market, By Product, 2011–2018 ($Million)
Table 35 North America: Market, By Application, 2011–2018 ($Million)
Table 36 North America: Market, By End User, 2011–2018 ($Million)
Table 37 Europe: Market, By Technology, 2011–2018 ($Million)
Table 38 Europe: Ultra High Throughput Screening Market, By End User, 2011–2018 ($Million)
Table 39 Europe: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 40 Europe: Lab-on–A-Chip Market, By End User, 2011–2018 ($Million)
Table 41 Europe: Label-Free Technology Market, By End User, 2011–2018 ($Million)
Table 42 Europe: Market, By Product, 2011–2018 ($Million)
Table 43 Europe: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 44 Europe: Ultra High Throughput Screening Market, By Product, 2011–2018 ($Million)
Table 45 Europe: Lab-on-A-Chip Market, By Product, 2011–2018 ($Million)
Table 46 Europe: Label-Free Technology Market, By Product, 2011–2018 ($Million)
Table 47 Europe: Market, By Application, 2011–2018 ($Million)
Table 48 Europe: Market, By End User, 2011–2018 ($Million)
Table 49 Asia: Market, By Technology, 2011–2018 ($Million)
Table 50 Asia: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 51 Asia: Ultra High Throughput Screening Market, By End User, 2011–2018 ($Million)
Table 52 Asia: Lab-on-A-Chip Market, By End User, 2011–2018 ($Million)
Table 53 Asia: Label-Free Technology Market, By End User, 2011–2018 ($Million)
Table 54 Asia: Market, By Product, 2011–2018 ($Million)
Table 55 Asia: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 56 Asia: Ultra High Throughput Screening Market, By Product, 2011–2018 ($Million)
Table 57 Asia: Lab-on-A-Chip Market, By Product, 2011–2018 ($Million)
Table 58 Asia: Label-Free Technology Market, By Product, 2011–2018 ($Million)
Table 59 Asia: Market, By Application, 2011–2018 ($Million)
Table 60 Asia: Market, By End User, 2011–2018 ($Million)
Table 61 ROW: Market, By Technology, 2011–2018 ($Million)
Table 62 ROW: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 63 ROW: Ultra High Throughput Screening Market, By End User, 2011–2018 ($Million)
Table 64 ROW: Lab-on-A-Chip Market, By End User, 2011–2018 ($Million)
Table 65 ROW: Label-Free Technology Market, By End User, 2011–2018 ($Million)
Table 66 ROW: Market, By Product, 2011–2018 ($Million)
Table 67 ROW: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 68 ROW: Ultra High Throughput Screening Market, By Product, 2011–2018 ($Million)
Table 69 ROW: Lab-on-A-Chip Market, By Product, 2011–2018 ($Million)
Table 70 ROW: Label-Free Technology Market, By Product, 2011–2018 ($Million)
Table 71 ROW: Market, By Application, 2011–2018 ($Million)
Table 72 ROW: Market, By End User, 2011–2018 ($Million)
Table 73 Other Mergers & Acquisitions (2011-2013)
Table 74 Other Agreements & Collaborations (2011-2013)
Table 75 Other Product Launch (2011-2013)


List of Figures (23 Figures)

Figure 1 Research Methodology for The High Throughput Screening Market
Figure 2 Market Size Estimation Methodology for The High Throughput Screening Market
Figure 3 Forecast Model
Figure 4 Data Triangulation Methodology (3600 Evaluation)
Figure 5 Global Market Revenue, By Geography, 2011–2018 ($Million)
Figure 6 HTS Share in Overall Drug Discovery Market (2013)
Figure 7 Global HTS Market, 2011 - 2018 ($Million) & Growth Rate
Figure 8 Market Dynamics for HTS
Figure 9 HTS Technologies Market, By Geography (2013)
Figure 10 Opportunity Matrix: HTS Technology Market (2013-2018)
Figure 11 HTS Market, By End-User, 2013 ($Million)
Figure 12 HTS Market Key Players: Geographic Reach Vs Product Portfolio (2013)
Figure 13 High Throughput Screening Technology Evolution
Figure 14 HTS Market Segmentation
Figure 15 New Product Launches
Figure 16 Technology Integration
Figure 17 Value Chain – Drug Discovery Process
Figure 18 Value Chain Analysis – High Throughput Screening Instruments
Figure 19 Porter’s Five Forces Analysis
Figure 20 HTS Market, By Technology, 2013 ($Million)
Figure 21 Global HTS Market, By End User, 2013 Vs.2018
Figure 22 Global HTS Market, Growth Phase, By Geography
Figure 23 Key Growth Strategies in The HTS Market, 2011–2013

In recent years, the high throughput screening (HTS) market has witnessed a large number of technological advancements, which has resulted in an increase in the rate of adoption of HTS in laboratories. The global HTS market was valued at $13,736 million in 2013 and is expected to reach $19,627 million by 2018, at a CAGR of 7.4%. The HTS market is broadly classified into five segments, namely, technologies, products, applications, end users, and geography.

The technology market is sub-divided into ultra high throughput screening, cell-based assays, lab-on-a chip, label-free technology, and bioinformatics. The cell-based assays segment dominated the HTS market in 2013, followed by the lab-on-a-chip segment. The HTS products market is broadly categorized into instruments, consumables/reagents, and software and services. The consumables/reagents segment dominated this market in 2013, with a market share of around 57%. The applications market is segmented into target identification, primary screening, toxicology, stem cell biology, and others. Target identification dominated the HTS applications market in 2013, followed by the primary screening market. The HTS market by end user is broadly categorized into pharmaceutical companies, biotechnology companies, academic and government institutes, contract research organizations (CROs), and others. The pharmaceuticals segment dominated the market in 2013, with a market share of around 48%.

The major factors driving the growth of the HTS market are technological innovations, open innovation models adopted by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in HTS technology by organizations. Moreover, the presence of a large untapped market in emerging countries and growth in outsourcing of drug discovery services especially in China and India are the various factors that are expected to provide growth opportunities for players in this market. However, the capital intensive nature of HTS and difficulties in assay development for novel target classes are the factors curbing the growth of this market.

The global HTS market is dominated by North America, followed by Europe. North America will continue to lead the global HTS market in the forecast period. Over the next five years, Asia is expected to grow at the highest CAGR of 9.1%. Factors such as growth in investments as well as the growth in the outsourcing industry, and favorable economic conditions are responsible for the high growth of the HTS market in Asia.

The major players in the HTS market include Agilent Technologies (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.), and Tecan Group (Switzerland), among others.

High Throughput Screening (HTS) Market - Forecast to 2018

High Throughput Screening (HTS) Market

High Throughput Screening (HTS) Market - Forecast to 2018

High Throughput Screening (HTS) Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports